These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

779 related items for PubMed ID: 25906779

  • 1. Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study.
    Bank IE, Dekker MS, Hoes AW, Zuithoff NP, Verheggen PW, de Vrey EA, Wildbergh TX, Timmers L, de Kleijn DP, Glatz JF, Mosterd A.
    Eur Heart J Acute Cardiovasc Care; 2016 Aug; 5(4):364-74. PubMed ID: 25906779
    [Abstract] [Full Text] [Related]

  • 2. Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: optimal cut-off point, diagnostic value and future opportunities in primary care.
    Willemsen RT, van Severen E, Vandervoort PM, Grieten L, Buntinx F, Glatz JF, Dinant GJ.
    Eur J Gen Pract; 2015 Aug; 21(3):156-63. PubMed ID: 25751665
    [Abstract] [Full Text] [Related]

  • 3. Point-of-care heart-type fatty acid binding protein versus high-sensitivity troponin T testing in emergency patients at high risk for acute coronary syndrome.
    Kellens S, Verbrugge FH, Vanmechelen M, Grieten L, Van Lierde J, Dens J, Vrolix M, Vandervoort P.
    Eur Heart J Acute Cardiovasc Care; 2016 Apr; 5(2):177-84. PubMed ID: 25666938
    [Abstract] [Full Text] [Related]

  • 4. Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
    Figiel Ł, Wraga M, Bednarkiewicz Z, Lipiec P, Smigielski J, Krzemińska-Pakuła M, Kasprzak JD.
    Kardiol Pol; 2011 Apr; 69(1):1-6. PubMed ID: 21267954
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic accuracy of quantitative heart-fatty acid binding protein assays compared with Cardiodetect(®) in the early detection of acute coronary syndrome.
    Charpentier S, Maupas-Schwalm F, Cournot M, Elbaz M, Ducassé JL, Bottela JM, Lauque D.
    Arch Cardiovasc Dis; 2011 Oct; 104(10):524-9. PubMed ID: 22044705
    [Abstract] [Full Text] [Related]

  • 6. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł, Kasprzak JD, Peruga J, Lipiec P, Drozdz J, Krzemińska-Pakuła M, Smigielski J.
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [Abstract] [Full Text] [Related]

  • 7. Incremental value of heart-type fatty acid-binding protein in suspected acute myocardial infarction early after symptom onset.
    Schoenenberger AW, Stallone F, Walz B, Bergner M, Twerenbold R, Reichlin T, Zogg B, Jaeger C, Erne P, Mueller C.
    Eur Heart J Acute Cardiovasc Care; 2016 Apr; 5(2):185-92. PubMed ID: 25681485
    [Abstract] [Full Text] [Related]

  • 8. No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.
    Poldervaart JM, Röttger E, Dekker MS, Zuithoff NP, Verheggen PW, de Vrey EA, Wildbergh TX, van 't Hof AW, Mosterd A, Hoes AW.
    PLoS One; 2015 Apr; 10(7):e0132000. PubMed ID: 26177390
    [Abstract] [Full Text] [Related]

  • 9. Heart Fatty Acid Binding Protein and cardiac troponin: development of an optimal rule-out strategy for acute myocardial infarction.
    Young JM, Pickering JW, George PM, Aldous SJ, Wallace J, Frampton CM, Troughton RW, Richards MA, Greenslade JH, Cullen L, Than MP.
    BMC Emerg Med; 2016 Aug 31; 16(1):34. PubMed ID: 27577952
    [Abstract] [Full Text] [Related]

  • 10. External validation of heart-type fatty acid binding protein, high-sensitivity cardiac troponin, and electrocardiography as rule-out for acute myocardial infarction.
    Van Hise CB, Greenslade JH, Parsonage W, Than M, Young J, Cullen L.
    Clin Biochem; 2018 Feb 31; 52():161-163. PubMed ID: 29054440
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of a heart-type fatty acid-binding protein (H-FABP) bedside test in suspected acute coronary syndrome in primary care.
    Bruins Slot MH, Rutten FH, van der Heijden GJ, Doevendans PA, Mast EG, Bredero AC, van der Spoel OP, Glatz JF, Hoes AW.
    Int J Cardiol; 2013 Sep 30; 168(2):1485-9. PubMed ID: 23332896
    [Abstract] [Full Text] [Related]

  • 12. Performances of the heart fatty acid protein assay for the rapid diagnosis of acute myocardial infarction in ED patients.
    Dupuy AM, Cristol JP, Kuster N, Reynier R, Lefebvre S, Badiou S, Jreige R, Sebbane M.
    Am J Emerg Med; 2015 Mar 30; 33(3):326-30. PubMed ID: 25547666
    [Abstract] [Full Text] [Related]

  • 13. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T.
    McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.
    Eur Heart J; 2008 Dec 30; 29(23):2843-50. PubMed ID: 18682444
    [Abstract] [Full Text] [Related]

  • 14. Early Exclusion of Major Adverse Cardiac Events in Emergency Department Chest Pain Patients: A Prospective Observational Study.
    Leung YK, Cheng NM, Chan CP, Lee A, Wong JK, Yan BP, Ahuja AT, Graham CA, Rainer TH.
    J Emerg Med; 2017 Sep 30; 53(3):287-294. PubMed ID: 28992867
    [Abstract] [Full Text] [Related]

  • 15. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
    Kitamura M, Hata N, Takayama T, Hirayama A, Ogawa M, Yamashina A, Mera H, Yoshino H, Nakamura F, Seino Y.
    Heart Vessels; 2016 Jun 30; 31(6):907-17. PubMed ID: 26081026
    [Abstract] [Full Text] [Related]

  • 16. Heart fatty acid-binding protein in combination with the 80-lead body surface potential map improves early detection of acute myocardial infarction in patients who are cardiac troponin T-negative at presentation.
    Daly MJ, McCann CJ, Owens CG, Harbinson MT, Adgey JA.
    J Electrocardiol; 2011 Jun 30; 44(4):432-8. PubMed ID: 21529821
    [Abstract] [Full Text] [Related]

  • 17. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
    Ruzgar O, Bilge AK, Bugra Z, Umman S, Yilmaz E, Ozben B, Umman B, Meric M.
    Heart Vessels; 2006 Sep 30; 21(5):309-14. PubMed ID: 17151819
    [Abstract] [Full Text] [Related]

  • 18. [The significance of a 4,183 Da peptide of dermcidin protein in the early diagnosis and differential diagnosis of acute coronary syndrome].
    Kai F, Lifeng L, Haijing S, Xianhua L, Hu X.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Dec 30; 27(12):970-4. PubMed ID: 27318339
    [Abstract] [Full Text] [Related]

  • 19. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department.
    Charpentier S, Ducassé JL, Cournot M, Maupas-Schwalm F, Elbaz M, Baixas C, Juchet H, Lang T, Lauque D.
    Acad Emerg Med; 2010 Jan 30; 17(1):27-35. PubMed ID: 20078436
    [Abstract] [Full Text] [Related]

  • 20. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome.
    Nakata T, Hashimoto A, Hase M, Tsuchihashi K, Shimamoto K.
    Cardiology; 2003 Jan 30; 99(2):96-104. PubMed ID: 12711885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.